OYE Therapeutics Investors

Invest in OYE - invest in the future

OYE anticipates completing a near term clinical development and regulatory milestone upon receipt of the full readout of our Phase II human clinical study Q1/2022.

Value Proposition

"Open Your Eyes" is traditionally the first instruction you hear upon waking from general anesthesia following a medical procedure. OYE is making that easier for the patient and the medical professional. It's also our internal mandate to improve the patient experience through observation of the clinical process. Our mission is to save lives by filling gaps in care that have been overlooked.

Research agreement focuses on battlefield injuries

OYE Therapeutics Inc., a Purdue University-affiliated company, is working to reduce the mortality and morbidity resulting from injuries on the battlefield through the development of new life-saving strategies.
OYE is located in the Purdue Technology Center in the Purdue Research Park of Northwest Indiana.
The company has entered into a Cooperative Research and Development Agreement (CRADA) with the Uniformed Services University of the Health Sciences (USU), an institution of higher learning within the U.S. Department of Defense and The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. (HJF).
The partnership includes researching the effectiveness of OYE-002 to enhance acute pain control at the point-of-injury, cognitive processing, psychomotor resilience and mission capabilities.

Invest in OYE - invest in the future

Value Proposition​

Research agreement focuses on battlefield injuries

OYE Therapeutics®

Value Proposition